Publication Programs: Platform

A machine learning approach incorporating germline information improves genotyping of CRISPR-Cas9 gene editing events at single cell resolution […]

Read More… from Rocky Conference – 2022 – Poster Presentation 71

Efficient Multiplex Gene Editing of CD33 and CLL-1 in Human Hematopoietic Stem Cells Enables the Potential of Next-Generation Transplants for AML Treatment […]

Read More… from ASH – 2022 – Poster Presentation 4587

Functional Validation of Single Domain Antibody-Derived CD33 Specific CAR-T Cells for the Treatment of Acute Myeloid Leukemia […]

Read More… from SITC – 2022 – Poster Presentation P334

Multiplex deletion of myeloid antigens by base editing in human hematopoietic stem and progenitor cells (HSPCs) enables potential for next generation transplant for acute myeloid leukemia (AML) treatment […]

Read More… from ESGCT – 2022 – Poster Presentation P432

Efficient knockout of both CD33 and CLL-1 by multiplex genome editing of human hematopoietic stem cells enhances the potential of next- generation transplants for acute myeloid leukemia (AML) treatment […]

Read More… from ESGCT – 2022 – Poster Presentation P150

Automated Closed Cell Processing System De-Risks Gene-Edited CD34+ Hematopoietic Stem Cell Manufacturing […]

Read More… from Bioprocess International – 2022 – Poster Presentation CT11

TransACT enhances detection and characterization of translocation events from high-throughput sequencing data at base-pair resolution for gene editing products […]

Read More… from ISMB – 2022 – Poster Presentation 859